Global Psoriasis Therapeutics Market 2012-2016
Global
Psoriasis Therapeutics market to grow at a CAGR of 4.06 percent over the period
2012-2016. One of the key factors contributing to this market growth is the
increasing uptake of biologics. The Global Psoriasis Therapeutics market has
also been witnessing an increased focus on using combination therapies for
treating psoriasis. However, the adverse side effects associated with psoriatic
drugs could pose a challenge to the growth of this market.
To Read The Complete Report with
TOC:-
http://www.marketresearchreports.biz/analysis-details/global-psoriasis-therapeutics-market-2012-2016
Global
Psoriasis Therapeutics Market 2012-2016, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market
in the Americas, and the EMEA and APAC regions; it also covers the Global
Psoriasis Therapeutics market landscape and its growth prospects in the coming
years. The report also includes a discussion of the key vendors operating in
this market.
The
key vendors dominating this space include Amgen Inc., Pfizer Inc., Janssen
Biotech Inc., and Abbvie Inc.
The
other vendors mentioned in the report are AstraZeneca plc, Bristol Myers Squibb
Co., Celgene Corp., Celgene Corp., Eisai Co. Ltd., Eli Lilly and Co.,
GlaxoSmithKline plc, Incyte Corp., Isotechnika Inc., LEO Pharma A/S, Merck
& Co. Inc., and Novartis International AG
To Buy a Copy Of This Report:-
UCB
S.A. Key questions answered in this report:
·
What will the
market size be in 2016 and what will be the growth rate?
·
What are key
market trends?
·
What is driving
this market?
·
What are the
challenges to market growth?
·
Who are the key
vendors in this market space?
·
What are the
market opportunities and threats faced by key vendors?
·
What are the
strengths and weaknesses of each of these key vendors?
Contact:-
M/s
Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment